Prostacyclin treatment and clinical outcome in severe traumatic brain injury patients managed with an ICP-targeted therapy: A prospective study

Brain Injury

Volumn 26, Issue 1, 2012, Pages 67-75

  Olivecrona, Magnus ^a   Rodling Wahlström, Marie ^a   Naredi, Silvana ^a   Koskinen, Lars Owe D ^a  

^a UMEÅ UNIVERSITY   (Sweden)

Author keywords

ICP; long time; Outcome; prostacyclin; severe traumatic brain injury

Indexed keywords

ALBUMIN; BARBITURIC ACID DERIVATIVE; CLONIDINE; FUROSEMIDE; METOPROLOL; PROSTACYCLIN;

ADD ON THERAPY; ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BRAIN PERFUSION; CLINICAL ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; GLASGOW COMA SCALE; HUMAN; INTRACRANIAL PRESSURE MONITORING; LOW DRUG DOSE; MALE; PREDICTION; PROGNOSIS; RANDOMIZED CONTROLLED TRIAL; STRUCTURED INTERVIEW; SURVIVAL TIME; TRAUMATIC BRAIN INJURY; TREATMENT OUTCOME;

EID: 83055170870     PISSN: 02699052     EISSN: 1362301X     Source Type: Journal    
DOI: 10.3109/02699052.2011.635351     Document Type: Article

References (37)

1. Clifton GL, Miller ER, Choi SC, Levin HS, McCauley S, Smith Jr KR, Muizelaar JP, Wagner Jr FC, Marion DW, Luerssen TG, et al. Lack of effect of induction of hypothermia after acute brain injury. New England Journal of Medicine 2001;344:556-563. (Pubitemid 32167869)
2. Corral L, Ventura JL, Herero JI, Monfort JL, Juncadella M, Gabarros A, Bartolome C, Javierre CF, Garcia-Huete L. Improvement in GOS and GOSE scores 6 and 12 months after severe traumatic brain injury. Brain Injury 2007;21: 1225-1231. (Pubitemid 351193500)
3. Papa L, Akinyi L, Liu MC, Pineda JA, Tepas 3rd JJ, Oli MW, Zheng W, Robinson G, Robicsek SA, Gabrielli A, et al. Ubiquitin C-terminal hydrolase is a novel biomarker in humans for severe traumatic brain injury. Critical Care in Medicine 2009;38:138-144.
4. Young B, Runge JW, Waxman KS, Harrington T, Wilberger J, Muizelaar JP, Boddy A, Kupiec JW. Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial. Journal of the American Medical Association 1996;276: 538-543. (Pubitemid 26272298)
5. Asgeirsson B, Grände PO, Nordström CH. A new therapy of post-trauma brain oedema based on haemodynamic principles for brain volume regulation. Intensive Care Medicine 1994;20: 260-267. (Pubitemid 24132365)
6. Grände PO, Asgeirsson B, Nordström CH. Physiologic principles for volume regulation of a tissue enclosed in a rigid shell with application to the injured brain. Journal of Trauma 1997;42:23-31.
7. Grände PO, Asgeirsson B, Nordström CH. Volume-targeted therapy of increased intracranial pressure: The Lund concept unifies surgical and non-surgical treatments. Acta Anaesthesiologica Scandinavica 2002;46:929-941.
8. Naredi S, Eden E, Zäll S, Stephensen H, Rydenhag B. A standardized neurosurgical neurointensive therapy directed toward vasogenic edema after severe traumatic brain injury: Clinical results. Intensive Care Medicine 1998;24:446-451. (Pubitemid 28274156)
9. Naredi S, Olivecrona M, Lindgren C, Ö stlund AL, Grände PO, Koskinen LO. An outcome study of severe traumatic head injury using the "Lund therapy" with lowdose prostacyclin. Acta Anaesthesiologica Scandinavica 2001;45:402-406. (Pubitemid 32234730)
10. Olivecrona M, Rodling-Wahlström M, Naredi S, Koskinen LO. Effective ICP reduction by decompressive craniectomy in patients with severe traumatic brain injury treated by an ICP-targeted therapy. Journal of Neurotrauma 2007;24:927-935. (Pubitemid 47015428)
11. Olivecrona M, Rodling-Wahlström M, Naredi S, Koskinen L-OD. Prostacylin treatment in severe traumatic brain injury - a microdialysis and outcome study. Journal of Neurotrauma 2009;26:1251-1262.
12. Scherer W, Uekö tter B, Hoffmann A, Sephernia A. Ten years experiences with the Lund concept and early rehabilitation in patients with severe traumatic brain injury. European Journal of Anaestesiology 2008;25(Suppl 43):7.
13. Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow Outcome Scale and the extended Glasgow Outcome Scale: Guidelines for their use. Journal of Neurotrauma 1998;15:573-585.
14. Jennett B, Bond M. Assessment of outcome after severe brain damage. Lancet 1975;1:480-484.
15. Marshall LF, Marshall SB, Klauber MR, van Berkum Clark M, Eisenberg HM, Jane JA, Luerssen TG, Marmarou A, Foulkes MA. A new classification of head injury based on computerized tomography. Journal of Neurosurgery 1991;75:S14-S20.
16. Eker C, Asgeirsson B, Grände PO, Schalen W, Nordström CH. Improved outcome after severe head injury with a new therapy based on principles for brain volume regulation and preserved microcirculation. Critical Care in Medicine 1998;26:1881-1886. (Pubitemid 28527702)
17. Roozenbeek B, Maas AI, Marmarou A, Butcher I, Lingsma HF, Lu J, McHugh GS, Murray GD, Steyerberg EW. The influence of enrollment criteria on recruitment and outcome distribution in traumatic brain injury studies: Results from the impact study. Journal of Neurotrauma 2009;26:1069-1075.
18. Bailey I, Bell A, Gray J, Gullan R, Heiskanan O, Marks PV, Marsh H, Mendelow DA, Murray G, Ohman J, et al. A trial of the effect of nimodipine on outcome after head injury. Acta Neurochirurgica (Wien) 1991;110:97-105.
19. Joosse P, Smit G, Arendshorst RJ, Soedarmo S, Ponsen KJ, Goslings JC. Outcome and prognostic factors of traumatic brain injury: A prospective evaluation in a Jakarta University hospital. Journal of Clinical Neuroscience 2009;16:925-928.
20. Maas AI, Murray G, Henney 3rd H, Kassem N, Legrand V, Mangelus M, Muizelaar JP, Stocchetti N, Knoller N. Efficacy and safety of dexanabinol in severe traumatic brain injury: Results of a phase III randomised, placebocontrolled, clinical trial. Lancet Neurol 2006;5:38-45. (Pubitemid 41790694)
21. Marshall LF, Maas AI, Marshall SB, Bricolo A, Fearnside M, Iannotti F, Klauber MR, Lagarrigue J, Lobato R, Persson L, et al. A multicenter trial on the efficacy of using tirilazad mesylate in cases of head injury. Journal of Neurosurgery 1998;89:519-525. (Pubitemid 28440918)
22. Martins ET, Linhares MN, Sousa DS, Schroeder HK, Meinerz J, Rigo LA, Bertotti MM, Gullo J, Hohl A, Dal-Pizzol F, et al. Mortality in severe traumatic brain injury: A multivariated analysis of 748 Brazilian patients from Florianopolis City. Journal of Trauma 2009;67:85-90.
23. Morris GF, Bullock R, Marshall SB, Marmarou A, Maas A, Marshall LF. Failure of the competitive N-methyl- D-aspartate antagonist Selfotel (CGS 19755) in the treatment of severe head injury: Results of two phase III clinical trials. The Selfotel Investigators. Journal of Neurosurgery 1999;91:737-743. (Pubitemid 30053144)
24. Murray GD, Teasdale GM, Braakman R, Cohadon F, Dearden M, Iannotti F, Karimi A, Lapierre F, Maas A, Ohman J, et al. The European Brain Injury Consortium survey of head injuries. Acta Neurochirurgica (Wien) 1999;141:223-236. (Pubitemid 29137535)
25. Murray LS, Teasdale GM, Murray GD, Miller DJ, Pickard JD, Shaw MD. Head injuries in four British neurosurgical centres. British Journal of Neurosurgery 1999;13:564-569. (Pubitemid 30009119)
26. Xiao G, Wei J, Yan W, Wang W, Lu Z. Improved outcomes from the administration of progesterone for patients with acute severe traumatic brain injury: A randomized controlled trial. Critical Care 2008;12:R61.
27. Marmarou A, Nichols J, Burgess J, Newell D, Troha J, Burnham D, Pitts L. Effects of the bradykinin antagonist Bradycor (deltibant, CP-1027) in severe traumatic brain injury: Results of a multi-center, randomized, placebocontrolled trial. American Brain Injury Consortium Study Group. Journal of Neurotrauma 1999;16:431-444.
28. El-Adawy Y, Rosner M. Cerebral perfusion pressure, autoregulation and the PVI reflection point: Pathological ICP. In: Hoff J, Betz A, editors. Intracranial pressure VII. Berlin Heidelberg: Springer-Verlag; 1989. pp 829-833.
29. Gray WJ, Rosner MJ. Pressure-volume index as a function of cerebral perfusion pressure. Part 1: The effects of cerebral perfusion pressure changes and anesthesia. Journal of Neurosurgery 1987;67:369-376. (Pubitemid 17128354)
30. McGraw C. A cerebral perfusion pressure greater than 80mmHg is more beneficial. In: Hoff J, Betz A, editors. Intracranial pressure VII. Berlin Heidelberg: Springer Verlag; 1989. pp 839-841.
31. Rosner MJ, Daughton S. Cerebral perfusion pressure management in head injury. Journal of Trauma 1990;30:933-940; discussion 940-931.
32. Rosner MJ, Rosner SD, Johnson AH. Cerebral perfusion pressure: Management protocol and clinical results. Journal of Neurosurgery 1995;83:949-962. (Pubitemid 26048132)
33. Bratton SL, Chestnut RM, Ghajar J, McConnell Hammond FF, Harris OA, Hartl R, Manley GT, Nemecek A, Newell DW, Rosenthal G, et al. Guidelines for the management of severe traumatic brain injury. IX. Cerebral perfusion thresholds. Journal of Neurotrauma 2007;24(Suppl 1):59-64.
34. Balestreri M, Czosnyka M, Hutchinson P, Steiner LA, Hiler M, Smielewski P, Pickard JD. Impact of intracranial pressure and cerebral perfusion pressure on severe disability and mortality after head injury. Neurocritical Care 2006;4: 8-13. (Pubitemid 43269454)
35. Palmer S, Bader MK, Qureshi A, Palmer J, Shaver T, Borzatta M, Stalcup C. The impact on outcomes in a community hospital setting of using the AANS traumatic brain injury guidelines. Americans Associations for Neurologic Surgeons. Journal of Trauma 2001;50:657-664. (Pubitemid 32336250)
36. Patel HC, Bouamra O, Woodford M, King AT, Yates DW, Lecky FE. Trends in head injury outcome from 1989 to 2003 and the effect of neurosurgical care: An observational study. Lancet 2005;366:1538-1544. (Pubitemid 41540111)
37. Olivecrona M, Zetterlund B, Rodling-Wahlstrom M, Naredi S, Koskinen LO. Absence of electroencephalographic seizure activity in patients treated for head injury with an intracranial pressure-targeted therapy. Journal of Neurosurgery 2009;110:300-305.